Journal of Breast Imaging CME-CE Article
Volume 1, Issue 1, March 2019

Article title: Pearls and Pitfalls of Contrast-Enhanced Mammography

Date(s) of Activity: March 1, 2019 – March 1, 2022

This activity is jointly provided by the American College of Radiology and the Society of Breast Imaging.

Access March JBI CME

CEM has been FDA approved as a diagnostic breast imaging tool to supplement mammography and ultrasound in the evaluation for breast cancer. Multiple studies have shown its value for evaluating patients with newly diagnosed breast cancer, patients with symptomatic breasts, patients recalled from screening mammography, and patients undergoing neoadjuvant chemotherapy (1-5). At this time, knowledge of CEM and its value for diagnostic imaging is not well-known. This activity describes the history of CEM, the current imaging technique, the benefits of the imaging modality in regards to clinical performance, cost, and ease of implementation, how to interpret and report the imaging exam, how to implement the modality into clinical practice, and some challenges.

Educational/Learning Objectives

After completing this activity, the participant should be better able to:

  • To review the history of CEM and the current imaging technique
  • To provide an overview of CEM interpretation and reporting
  • To examine current and future indications for CEM
  • To outline key components to clinical implementation
  • To review benefits and challenges of CEM


SBI Member - $0 - Complimentary
Non-Member - $50

Not a member? Join SBI and take advantage of the member benefits all year long!

Accreditation Information

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The American College of Radiology and The Society of Breast Imaging. The American College of Radiology is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation:

The American College of Radiology designates this journal-based activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American College of Radiology is approved by the American Registry of Radiologic Technologists (ARRT) as a Recognized Continuing Education Evaluation Mechanism (RCEEM) to sponsor and/or review Continuing Medical Educational programs for Radiologic Technologists and Radiation Therapists.

Credit Designation Statement:
The American College of Radiology designates this educational activity as meeting the criteria for up to 1 Category A credit hours of the ARRT.

Instructions to Receive Credit:
In order to successfully complete the activity, participants must score 80% or higher on the post-test at the end of the activity and complete the activity evaluation. Each participant has a maximum of three attempts to score an 80%. Upon successful completion the participant may claim credit commensurate with their participation in the activity.

Contact Information:
For information about the accreditation of this program, please contact the ACR at

Disclosure of Conflicts of Interest:
The ACR Disclosure Policy:  In compliance with ACCME requirements and guidelines, the ACR has developed a policy for disclosure and review of potential conflicts of interest, and a method for resolution if a conflict does exist. The ACR maintains a tradition of scientific integrity and objectivity in its educational activities. In order to preserve these values and ensure its educational activities are independent and free of commercial bias, all individuals, including planners, presenters, moderators and evaluators, participating in an ACR educational activity, or an activity jointly provided by the ACR must disclose all relevant financial relationships with any commercial interest.

The following planners and managers have no financial relationships to disclose: Ana Lourenco, MD; Jordana Phillips, MD; Valerie J. Fein-Zachary, MD; Priscilla J. Slanetz, MD, MPH; Yasmeen Fields, CAE.